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Abstract
Background : Myxobacteria have been well established as a
potent source for natural products with biological activity. They
produce a considerable variety of compounds which represent
typical polyketide structures with incorporated amino acids (e.g.
the epothilons, the myxothiazols and the myxalamids). Several of
these secondary metabolites are effective inhibitors of the electron
transport via the respiratory chain and have been widely used.
Molecular cloning and characterization of the genes governing the
biosynthesis of these structures is of considerable interest, because
such information adds to the limited knowledge as to how
polyketide synthases (PKSs) and non-ribosomal peptide synthe-
tases (NRPSs) interact and how they might be manipulated in
order to form novel antibiotics.
Results : A DNA region of approximately 50 000 base pairs from
Stigmatella aurantiaca Sga15 was sequenced and shown by gene
disruption to be involved in myxalamid biosynthesis. Sequence
analysis reveals that the myxalamids are formed by a combined
PKS/NRPS system. The terminal NRPS MxaA extends the
assembled polyketide chain of the myxalamids with alanine.
MxaA contains an N-terminal domain with homology to NAD
binding proteins, which is responsible during the biogenesis for a
novel type of reductive chain release giving rise to the 2-amino-
propanol moiety of the myxalamids. The last module of the PKS
reveals an unprecedented genetic organization; it is encoded on
two genes (mxaB1 and mxaB2), subdividing the domains of one
module from each other. A sequence comparison of myxobacterial
acyl-transferase domains with known systems from streptomycetes
and bacilli reveals that consensus sequences proposed to be
specific for methylmalonyl-CoA and malonyl-CoA are not always
reliable.
Conclusions : The complete biosynthetic gene cluster of the
myxalamid-type electron transport inhibitor from S. aurantiaca
Sga15 has been cloned and analyzed. It represents one of the few
examples of combined PKS/NRPS systems, the analysis and
manipulation of which has the potential to generate novel hybrid
structures via combinatorial biosynthesis (e.g. via module-swap-
ping techniques). Additionally, a new type of reductive release
from PKS/NRPS systems is described. ß 2001 Elsevier Science
Ltd. All rights reserved.
Keywords: Biosynthetic gene cluster; Myxalamid; Myxobacterium; Re-
ductive chain termination; Polyketide synthase/peptide synthetase
1. Introduction
Polyketides and non-ribosomal peptides represent large
families of natural products that are assembled using acyl-
coenzyme A or amino acid building blocks. Numerous
chemical compounds belonging to these groups are widely
used as pharmaceuticals, veterinary agents or agrochemi-
cals. Both types are biosynthesized by extremely large poly-
functional enzyme systems, which are organized in mod-
ules. Each module is responsible for one discrete chain
elongation step and can be subdivided into domains con-
trolling the choice of the extender unit and several types of
modi¢cations that can take place on each intermediate.
The responsible biosynthetic proteins are known as poly-
ketide synthases (PKSs) and non-ribosomal polypeptide
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synthetases (NRPS) [1]. Until the ¢rst hybrid systems were
described recently (see below), these biosynthetic machi-
neries have been regarded as unrelated and studied sepa-
rately.
Myxobacteria are Gram-negative soil bacteria that be-
long to the N-group of the Proteobacteria [2]. They have
been shown to produce an immense variety of secondary
metabolites with biological activity (for reviews see [3,4]).
Among these are the electron transport inhibitors of the
myxothiazol type and the epothilons, which represent
promising anticancer agents. These and several other myxo-
bacterial secondary metabolites seem to be biosynthesized
by combined PKS/NRPS systems (compare Fig. 1), a few
of which have been recently cloned and sequenced [5^7].
From the rapidly growing knowledge of PKS and NRPS
systems (for a review see [1]), which is based primarily on
research with actinomycetes [8,9], only few hybrid PKS/
NRPS systems have been described (rapamycin [10,11],
naphthomycin [12], bleomycin [13]), whereas from myxo-
bacteria and other alternative sources of natural products
more information in terms of combinations and novel bio-
synthetic features has been recently gained. Currently four
completely sequenced systems have been described, in
which modules of PKS and NRPS were even found on
single hybrid genes (yersiniabactin of Yersinia pestis [14],
myxothiazol of Stigmatella aurantiaca [5], microcystin of
Microcystis aeruginosa [15] and mycosubtilin of Bacillus
subtilis [16]). Combinations of both types of systems
have gained a lot of attention due to their potential to
generate novel hybrid structures [17].
Myxothiazol [18] and the myxalamids [3,19] represent
two electron transport inhibitors, which are produced by
several strains of S. aurantiaca and both belong to the type
of molecules described above. We recently reported the
analysis of the gene cluster for myxothiazol [5] and iden-
ti¢ed a DNA fragment encoding part of a L-ketoacyl-syn-
thase (KS) domain of the myxalamid biosynthetic gene
cluster in a general screening approach aimed at the iso-
lation of combined PKS/NRPS gene clusters from myxo-
bacteria [20]. Additionally the myxalamids contain unusu-
al features (Fig. 1) : the isoleucine and valine derived
starter units 2-methyl-butyryl-CoA and isobutyryl-CoA
are used and the polyene-polyketide backbone is linear,
terminating in a 2-amino-propanol structure derived
from the amino acid alanine (compare [21]).
This communication deals with the characterization of
the hybrid PKS/NRPS gene cluster from S. aurantiaca
Sga15 that is involved in myxalamid biosynthesis. It com-
prises genes encoding PKS and NRPS, the inactivation of
which impairs myxalamid biosynthesis.
2. Results and discussion
2.1. Cloning and identi¢cation of the myxalamid gene
cluster via gene disruption
A cosmid library of S. aurantiaca Sga15 was prepared.
Subsequently a variety of cosmids hybridizing to PKS and
NRPS probes were isolated and used to amplify speci¢c
KS fragments of the PKS genes encoded on the respective
DNA locus. One of these fragments, ampli¢ed from cos-
mid C2, was used for a gene inactivation experiment in S.
aurantiaca Sga15 and resulted in a myxalamid negative
phenotype [20]. The sequence of cosmid C2 was deter-
mined, revealing the presence of several open reading
frames (ORFs) with similarity to PKSs which were desig-
nated mxaB^D (myxalamid; see Fig. 2). In addition, one
further ORF with similarity to NRPSs was detected
(mxaA). In order to verify the expected involvement of
Fig. 1. Structures of natural products isolated from myxobacteria.
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mxaA in myxalamid biogenesis, a gene disruption mutant
was made by insertion of a PCR generated fragment of
mxaA into the chromosome of S. aurantiaca Sga15, result-
ing in mutant strain CBS17 (compare Fig. 2). The mutant
was veri¢ed via Southern analysis (data not shown) and
shown to be unable to produce myxalamids (see Fig. 3).
Subsequently a cosmid with minimized overlap was iso-
lated from the library (cosmid CS2a, see Fig. 2) as de-
scribed in Section 3. The sequence of the insert was ana-
lyzed as described and found to overlap with mxaC. Three
further PKS genes oriented into the same direction as
mxaA^C were identi¢ed and designated mxaD^F. Analysis
of the modular structure of the myxalamid megasynthe-
tase revealed that mxaF most likely encodes the ¢rst mod-
ule of the biosynthetic gene cluster (see below). Thus mxaF
was subjected to another gene inactivation experiment as
described above and the veri¢ed mutant was found to be a
myxalamid non-producing strain (see Figs. 2 and 3).
2.2. Sequence analysis of the myxalamid biosynthetic genes
The modular organization of PKSs involves activation
and condensation of the following carboxylic acid onto
the growing chain catalyzed by an acyl-transferase (AT)
domain and a KS domain. The resulting L-keto acid may
subsequently be processed by L-ketoacyl-reductase (KR)
domains, L-hydroxy-acyl-dehydratase (DH) domains and
enoyl-reductase (ER) domains (reviewed in [1]). Addition-
al domains for C-methylation [14,22] and O-methylation
[5] of intermediates have recently been reported. Sequence
motifs typical for these domains in PKSs [10,23] and
NRPSs [24,25] were detected in MxaA^F as shown in
Table 1 and Fig. 4. The acyl carrier protein (ACP) do-
mains and the peptidyl carrier protein (PCP) domain of
MxaA^F contain the Prosite consensus signature of the
Fig. 2. Myxalamid biosynthetic gene cluster. E show regions ampli¢ed via PCR which were used for the gene inactivation constructions.
Fig. 3. HPLC analysis of mutants. The analysis of a kanamycin resis-
tant mutant of S. aurantiaca Sga15 (strain BS38) grown under the same
conditions as the myxalamid mutant BS39 is shown. M-A, myxalamid
A; M-B, myxalamid B; M-C, myxalamid C; M-D, myxalamid D; M-?,
unknown structural variant of the myxalamids; MS, myxochromid S;
S, stigmatellin; A, aurachin A; DAD, diode array detection; mAU, milli-
absorption units.
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putative binding site for the 4P-phosphopantetheine
(Ppant) co-factor (Prosite signature number PS00012,
R2082 and L2104). The codon bias (see Table 1) of the
genes reported is in accordance with other genes from
myxobacteria [26]. The last module of the PKS part of
the cluster is encoded on two genes, which to date is with-
out precedent in other PKS systems. Initially we thought
that this ¢nding was due to a sequencing error and re-
evaluated the DNA region, in which a frame shift would
result in the module being encoded on one single ORF.
Table 1
Deduced functions of ORFs in the myxalamid biosynthetic gene cluster
Polypeptide (modules) Amino acids GC bias 1st, 2nd, 3rd position Proposed function
MxaF 2368 71/50/86 PKS domains:
Loading+module 1: ACPL, KS, ATL, AT1, DH, KR, ACP2
MxaE 1862 71/51/83 PKS domains:
Module 2: KS, AT, DH, KR, ACP
MxaD 1840 73/49/83 PKS domains:
Module 3: KS, AT, DH, KR, ACP
MxaC 3291 71/50/84 PKS domains:
Module 4: KS, AT, DH, KR, ACP
Module 5: KS, AT, KR, ACP
Module 6: KS, AT, DH, KR, ACP
MxaB1 939 68/46/82 PKS domains:
Module 7: KS, AT
MxaB2 1233 77/53/73 PKS domains:
Module 7: DH, ER, KR, ACP
MxaA 1515 68/46/80 NRPS domains:
Module 8: Condensation, adenylation, PCP, reduction
Fig. 4. Model for myxalamid biosynthesis. PKS domains shown in green, NRPS domains shown in red. The unusual terminal reductase domain (Red)
of MxaA is indicated in yellow. ‘*’ indicates a presumably inactive domain. The biosynthesis of myxalamid S is shown (see text). S, spacer region.
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This region (1320 bp from the beginning of the AT do-
main in mxaB2 to the end of the DH domain in mxaB1)
was covered by sequencing reactions from cosmid C4 at
least four times on each DNA strand indicating no ambig-
uous region. In order to verify the sequence directly from
the chromosome, the region was ampli¢ed from S. auran-
tiaca Sga15 via PCR using a proofreading polymerase and
re-sequenced from four independently generated PCR
products. No di¡erences to the original sequence were
found. The overall G+C content of the sequenced mxa
region spanning approximately 55 kbp is 67%.
2.3. Model for the myxalamid biosynthetic pathway
The main component produced by S. aurantiaca Sga15,
myxalamid B (compare Fig. 4), was shown to block the
respiratory chain at the site of complex I in beef heart
submitochondrial particles, i.e. NADH:ubiquinone oxido-
reductase [19]. Here it is demonstrated, that the biosyn-
thetic machinery for the myxalamids follows a multi-step
process, resembling the biochemistry performed by type I
PKS and NRPS systems. Alternative starters can be used
to initiate the biosynthesis of the polyketide backbone
¢nally resulting in myxalamids A^D (compare Figs. 1
and 4). The modular structure of type I PKSs usually
starts with an AT or a CoA-ligase domain responsible
for the recognition (and, in the case of CoA-ligases, for
activation) of the starter molecule followed by transfer of
the activated substrate to the ¢rst ACP domain (compare
the biosynthetic gene clusters of erythromycin [23], rapa-
mycin [10,27] and rifamycin [28]). In the case of mxaF, the
modular organization looks di¡erent: the protein starts
with an ACPL, followed by KS, two ATs (ATL and
AT1), DH, KR followed by the second ACP2. The unusu-
al type of AT arrangement in MxaF has only been re-
ported twice in other proteins, which catalyze the ¢rst
steps of polyketide biogenesis in two other myxobacterial
compounds: soraphen (U.S. patent 5693774) from Soran-
gium cellulosum and myxothiazol [5] from S. aurantiaca
DW4/3-1. In these, as in myxalamid, unusual starter mol-
ecules are used: activated forms of benzoic acid derived
from phenylalanine in soraphen [29] and activated forms
of 3-methylbutyrate derived from leucine in myxothiazol
(see Fig. 1). We suppose that the ¢rst AT of MxaF (ATL)
is responsible for the recognition of the di¡erent starter
units used for myxalamid biosynthesis (2-methylbutyrate
in myxalamid A, isobutyrate in myxalamid B, propionate
in myxalamid C and acetate in myxalamid D), whereas the
second AT (ATL) loads methylmalonate, which is subse-
quently used for the ¢rst chain extension step (compare
Figs. 4 and 5). Whether the arrangement of the ATs is of
consequence for the speci¢city of the unusual starter mol-
ecules and the three-dimensional structure of the PKS,
remains to be determined. A comparison of the ATs of
the myxalamid biosynthetic proteins with the domains
of other known myxobacterial gene clusters (epothilon,
myxothiazol, soraphen) is given in Fig. 5, indicating that
the de¢nition of core regions, presumed to be responsible
for substrate speci¢city, is not always reliable. There are
several ATs that do not ¢t into the consensus sequences
published (e.g. [30,31]), the most striking examples being
the malonate speci¢c AT1 of MxaC and the methylmalonyl
speci¢c AT2 of the myxothiazol biosynthetic protein MtaB
(compare Fig. 5). The di⁄culty in assigning speci¢cities
for ATs can be exempli¢ed by a comparison of the AT
domains of the epothilon biosynthetic genes, which were
characterized by sequence comparison. AT2 of EpoC was
assigned malonate speci¢city to via sequence comparison
[6], and it was speculated that the methyl group at the
corresponding position, C12 in the epothilon B structure
(compare Fig. 1), is derived from an S-adenosyl-methio-
nine dependent methylation. Nevertheless, it is clear from
feeding experiments that the occurrence of the C12 methyl
group in epothilon B (which does not occur in epothilon
A; compare Fig. 1) is derived from alternative incorpora-
tion of malonate into epothilon A or methylmalonate into
epothilon B (Gerth, K., Reichenbach, H. and Ho«£e, G.,
unpublished). This clearly shows that AT2 of EpoC must
be able to accept both extender units. If one compares the
homology of the ATs, one additionally ¢nds that AT2 of
EpoC (accepting methyl-malonate and malonate) and AT1
of EpoC (processing only malonate) are almost identical
sequences, with just seven amino acids (aa) being ex-
changed in the 320 aa sequence, four of which are replaced
by similar aa (Fig. 5). It has recently been proposed that
an N-terminal 35 aa segment, encoded by an NheI-StyI
fragment of the DEBS AT2 domain or its counterparts in
other AT domains, plays an important role in controlling
the substrate speci¢city [32]. Nevertheless, there is only
one threonine^alanine exchange in this aa stretch in the
epothilon ATs mentioned. One highly conserved region
within ATs is the GHSxGE motif, in which the x position
is occupied by an isoleucine in AT1 and by an alanine in
AT2 of EpoC. Whether any of these slight exchanges is
responsible for the di¡erence in substrate recognition re-
mains to be determined, e.g. via site directed mutagenesis.
Fig. 5B shows that almost all of the aa believed to specify
malonate or methylmalonate recognition can be ex-
changed by their counterparts. In light of these exceptions
to the ‘speci¢city rules’ it seems hardly possible to de¢ne
new consensus sequences via sequence comparison alone.
Further studies are necessary, ideally involving the crystal-
lography of AT modules with their respective substrates.
As in peptide synthetase systems [33], the KS and also
possibly the ACP domains of polyketide synthases could
play an additional role in substrate speci¢city.
Subsequent action of KR and DH domains during myx-
alamid biosynthesis can be assumed to result in the ¢rst
double bond of the myxalamids (Fig. 4). Large spacer
regions (S) more than 300 aa in size are located between
the AT and the KR domains of each module. These have
been described for almost all PKS and fatty acid biosyn-
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thetic systems [1,34] but their function is not clear. These S
regions can also be found in all myxobacterial PKS
systems sequenced so far and show an identity of up to
35% on the aa level. In addition, they share up to 20%
identical aa with ER domains from di¡erent sources.
The S region present in module 1 even harbors an aa
stretch (LxLxxxSGVGxxLxxxL) which resembles the
LxHxxxGGVGxxAxxxA motif important for functionality
of ER domains [35]. Nevertheless, there is no indication
that these S regions may function as ER domains, because
myxalamid analogs without the corresponding double
bond have not been isolated (Ho«£e, G.; personal commu-
nication). MxaE^C contain the following ¢ve PKS mod-
ules necessary for chain extension (compare Fig. 4). In
addition, mxaE encodes a DH domain, which is not
needed for the assembly of the product. Although the
typical core region for DH domains (LxxHxxxGxxxxP)
can be found, one has to assume that this domain is in-
active. Interestingly, module 5 in MxaC lacks the DH
domain necessary to create myxalamids A^D. Myxalamid
S (compare Fig. 4) has also been isolated from S. auran-
tiaca Sga15 (Ho«£e, G., personal communication) repre-
senting the main compound (myxalamid B) derivative, in
which water elimination does not occur in the correspond-
ing position. Myxalamid S might be produced primarily
and water elimination may be performed by an enzyme
Fig. 5. Acyl-transferase domain alignment. A: Dendrogram of AT sequences from the epothilon (Epo; ref. see text), soraphen (Sor; ref. see text), myxo-
thiazol (Mta; ref. see text), myxalamid (Mxa), avermectin (Ave; [31]) and rifamycin (Rif ; [28]) biosynthetic proteins. Malonyl (m) and methylmalonyl
(mm) speci¢c ATs are shown in yellow and red, respectively. The ATs in blue are those with a di¡erent substrate speci¢city, which is referred to in the
dendrogram. The length of each pair of branches represents the distance between sequence pairs, while the units at the bottom of the tree indicate the
number of substitution events. A dotted line on a phenogram indicates a negative branch length. B: Alignment of the four AT domains discussed in
the text. Boxes indicate the regions believed to determine substrate speci¢city [31], with the consensus sequence for each region given below the align-
ment. Amino acids in bold are those that are believed to specify malonate or methyl-malonate binding. Amino acids shown in red in the alignments do
not ¢t into this hypothesis. Amino acids in green indicate the only di¡erences between AT1 and AT2 of EpoC. ‘*’ indicate identical, ‘ :’ similar aa.
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not encoded in the gene cluster, or by another DH domain
of the myxalamid megasynthetase (possibly the one en-
coded in mxaE). It may even occur non-enzymatically giv-
ing rise to the conjugated pentadiene in the myxalamids
A^D.
The growing chain is then extended by the MxaB1ÿ2
module, that is encoded on two separate proteins. One
can envisage here how domain fusions take place via mu-
tation, giving rise to type I systems. One single nucleotide
insertion could combine the complete module on one
ORF. MxaB1ÿ2 must interact during biogenesis, because
the ACP domain necessary for a minimal module (KS-AT-
ACP) is missing on MxaB1 and needs to be complemented
by the ACP on MxaB2 (Fig. 4). Relatively hydrophilic
amino-terminal linker regions resembling the interpolypep-
tide linkers de¢ned recently [36] can be found in the se-
quences separating the non-covalently connected modules.
These include the assumed interpolypeptide linker between
MxaB2 and MxaB1. MxaB2 carries an inactive ER do-
main (WxLxxxSGLGxxAxxxA instead of the conserved
LxHxxxGGVGxxAxxxA, see above).
Finally, the assembled polyketide is extended via MxaA,
the terminal NRPS present in the system. The adenylation
domain of MxaA carries all the core regions for A do-
mains in NRPS [24] and most likely it is this domain
which activates alanine, because feeding experiments
have been performed using Myxococcus stipitatus Mxs40,
which produces phenalamids. These natural products are
myxalamid derivatives with a starter unit derived from
phenyl acetate. In these experiments 13C-labelled alanine
was shown to be incorporated into the 2-amino-propanol
moiety of the phenalamids [21], indicating that the same
biochemistry is performed during myxalamid biosynthesis.
Although structure-based models for the amino acid rec-
ognition by NRPSs exist, speci¢city pocket structures for
alanine show weak homology [37,38]. During the review
process of this manuscript a publication occurred, in
which Shen and coworkers describe the bleomycin biosyn-
thetic gene cluster. They rede¢ne the consensus sequence
of the alanine binding pocket [39], the updated version of
which perfectly matches the sequence found in MxaA. The
condensation domain of MxaA harbors all the hallmarks
of a typical NRPS C domain [24] (C1: 232^262; C2: 370^
396; C3: 619^648; C4: 844^864; C5: 1075^1107; C6:
1183^1203; C7: 1231^1254) with some amino acid
changes, in comparison to the proposed core consensus
sequences. Whether these are responsible for the substrate
speci¢city of the myxalamid polyketide intermediate, that
is extended by MxaA, remains to be determined. mxaA
might be a good candidate gene to study PKS^NRPS
Fig. 5 (continued).
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interaction, because alternative polyketide intermediates
might be extended with alanine and reductively set free
from the PCP using mxaA in combinatorial approaches.
The chain termination process catalyzed by MxaA is
another interesting feature of the enzyme. The terminal
reductase domain contains an NAD(P)H binding site sim-
ilar to the one found in the Lys2 protein from Saccharo-
myces cerevisiae (compare Fig. 6), which was assumed to
be characteristic for a family of aminoacyladenylate form-
ing enzymes di¡erent from NRPS [40]. Biochemical char-
acterization of the lys2 gene product demonstrated that
the protein is responsible for the reduction of K-amino-
adipate to K-aminoadipate semialdehyde, which is fol-
lowed by a transamination giving rise to lysine [41] (com-
pare Fig. 7). We have cloned a second NRPS (MxcF)
harboring such a reductase domain from the myxochelin
biosynthetic operon of S. aurantiaca Sga15 [42]. Here it is
assumed that the reductase domain sets free the aldehyde
and might also be responsible for further reduction to the
alcohol structure found in myxochelin A (compare Fig. 7).
One further NRPS system is known to harbor an analo-
gous domain; this is the saframycin megasynthetase from
Myxococcus xanthus [43]. It is speculated that this enzyme
reductively releases a polypeptide intermediate, setting free
an aldehyde, that forms Schi¡ bases with free amino
groups of the molecule, ¢nally resulting in the formation
of saframycin. During myxalamid biogenesis the reductase
domain most likely performs the reductive release of the
Fig. 7. Proposed function of the reductase domains in MxaA (A), Lys2 (B) and MxcG (C). AT, amino-transferase.
Fig. 6. Alignment of the core regions of reductase domains. Aligned are the core regions of the domains of the saframycin synthetase (SafA), of the
probable polyketide synthase of Anabaena spec. (HetM; [49]), MxaA, MxcG [42] and of the K-aminoadipic acid reductase of Saccharomyces cerevisiae
[41]. Di¡erences to the core region [24] are indicated in bold. n.D. means that we were unable to detect the region in the sequence.
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hybrid polyketide/peptide, giving rise to the linear alde-
hyde and also further reduces the aldehyde to the terminal
2-amino-propanol structure present in the natural product
(compare Fig. 7). We sequenced downstream and up-
stream of the hypothetical ends of the myxalamid gene
cluster (approximately 15 kbp in each direction) and
did not detect any further gene with homology to oxido-
reductases that could be responsible for the reduction of
the aldehyde to the alcohol. Nevertheless, it cannot be
excluded that the released aldehyde is further processed
by an enzyme not encoded in the cluster. Interestingly,
there is also one example for a reductase domain being
present at the end of an uncharacterized PKS system
(HetM of Anabaena spec.), where most likely the ACP
bound thioester of the polyketide product is reductively
released.
2.4. De¢ning the border regions of the myxalamid
biosynthetic gene cluster
Analysing the sequence downstream of mxaA a putative
stem loop structure was found, indicating transcriptional
termination behind the gene (Fig. 2). Two further ORFs
(ORF1 and ORF2) were identi¢ed, encoding genes with
similarity to aspartokinases and histidine ammonia lyases,
respectively (compare Fig. 2). ORF2 was subjected to gene
inactivation experiments using pCBS21 but it was not pos-
sible to create mutants of the gene. This ¢nding indicates
that the gene encoding ORF2 is essential for growth and is
not related to myxalamid biosynthesis.
Upstream of mxaF a region of 264 bp can be found
which does not seem to encode any proteins. The next
putative ORF identi¢ed (ORF3, compare Fig. 2) shows
similarity to acetyl-transferases. The gene is divergently
transcribed from mxaF, indicating that a tandem promo-
tor is located within the 264 bp gap. Behind this gene
ORF4 similar to several transcriptional repressors can be
found. The encoding gene is divergently transcribed to
ORF3. No role for any of the detected proteins in myx-
alamid biogenesis is obvious. Whether the transcriptional
repressor has any relevance for the biosynthesis of the
secondary metabolite remains to be elucidated.
3. Signi¢cance
Polyketide synthases (PKSs) and non-ribosomal peptide
synthetases (NRPS) are large multifunctional and modular
enzyme systems which are responsible for the biosynthesis
of an immense variety of natural products with biological
activity. Understanding the genetic basis and the biochem-
istry of these systems facilitates genetic engineering aimed
at the rational design of novel structures with improved
activity. Recently biosynthetic pathways using natural hy-
brids of PKS and NRPS systems have gained a lot of
attention, because they enable the analysis of the co-oper-
ation of both enzyme types. The myxalamid biosynthetic
gene cluster of S. aurantiaca Sga15 represents one of the
few combined systems reported and analyzed to date. The
gene cluster reported is not only a promising candidate to
study further the interaction of PKS and NRPS, but also
reveals several novel biosynthetic features.
4. Materials and methods
4.1. Bacterial strains and culture conditions
Escherichia coli strains and S. aurantiaca Sga15 and its de-
scendants were cultured as described previously [44].
4.2. DNA manipulations, analysis, sequencing and PCR
Chromosomal DNA of S. aurantiaca strains was prepared as
described [45]. PCR was carried out using HotStarTaq Polymer-
ase (Qiagen) according to the manufacturer’s protocol. DMSO
was added to a ¢nal concentration of 5%. The conditions using
the Eppendorf gradient mastercycler were as follows: 15 min at
95‡C for activation of the polymerase, denaturation for 30 s at
95‡C, annealing for 30 s at 57^60‡C and extension for 45 s at
72‡C; 30 cycles and a ¢nal extension for 10 min at 72‡C. PCR
products were puri¢ed with the high pure PCR product puri¢ca-
tion kit (Roche Molecular Biochemicals). Screening of the cosmid
library of S. aurantiaca Sga15 [20] was performed as described [5].
The following primer pair was used to identify cosmid CS2a:
CS2A1: 5P-CCCGAATGGCCGCGTCACACC-3P and CS2A2:
5P-TCGGCATCAGCGGAACCAAC-3P. Clones giving ampli¢-
cation products of the expected size (465 bp) were counterselected
with primer pair CS2A3: 5P-CCCGCTGATGCCGAAGGAAC-
3P and CS2A4: 5P-CGTGCGTGGCGAGGGCTGTGG-3P to
identify a cosmid with minimal overlap.
Sequencing of cosmids CS2 and CS2a was performed by a
shotgun approach as follows: Sheared fragments of the two cos-
mids were subcloned separately into pTZ18R. At least 500 clones
were selected from each cosmid library, plasmid DNA prepared
(Millipore) and sequenced using DYEnamic1 ET terminator
cycle sequencing premix kit (Amersham Pharmacia Biotech)
and UPO/RPO primer (MWG-BioTech). The gels were run on
ABI-377 sequencers and data were assembled and edited using
the XGAP program [46]. In order to verify that mxaB is encoded
by two genes, Pfu polymerase (Stratagene) was used to amplify a
1320 bp PCR product from chromosomal DNA of S. aurantiaca
Sga15 using primers C24 (5P-CGGCTCGCCAGTTCCTCG-
TAATG-3P) and C26 (5P-TGGGGCACAGCATGGGGGA-
AGT-3P). Four independently ampli¢ed PCR products were se-
quenced and found to contain a DNA fragment identical to the
analogous fragment from cosmid C2. Southern analysis of DNA
was performed using the standard protocol for homologous
probes of the DIG high prime DNA labelling and detection start-
er kit II (Roche Molecular Biochemicals). All other DNA manip-
ulations were performed according to standard protocols [47].
Amino acid and DNA alignments were done using the programs
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Clustal W [48] and the Lasergene software package (DNASTAR
Inc.).
4.3. Construction and analysis of the S. aurantiaca Sga15 mutants
Two knock-out mutants unable to produce myxalamid have
been described [20]. These were generated using KS fragments
ampli¢ed by degenerate primers from cosmids hybridizing with
PKS probes. These mutants (C2, C14) carry the integrated plas-
mid in the region of KS2 and KS3 of mxaC. Using the primers
C3: 5P-AGGCTTGGCGGGCATGCTTGAGTA-3P and C4: 5P-
TCCGGAACGAGGCGCTGCTGTGTA-3P and cosmid CS2 as
template DNA, a fragment of mxaA (534 bp in size) was ampli-
¢ed and cloned into pCR2.1-TOPO using the TOPO TA cloning
kit (Invitrogen). The resulting plasmid pCBS17 was electropo-
rated after denaturation of the DNA into S. aurantiaca Sga15
[5] resulting in mutant CBS17. All other S. aurantiaca Sga15
mutants were constructed using the same approach. The mxaF
mutant CBS39 was obtained after electroporation with plasmid
pCBS39, which is a pCR2.1-TOPO derivative harboring a 590 bp
fragment, ampli¢ed by primers RM174: 5P-GCCCGCACAC-
GATCGTCAAGCACT-3P and RM175: 5P-CTCGATCGCCG-
CCCGGAAGACAGG-3P from cosmid CS2a.
We tried to obtain another set of mutants starting from a PCR
product (1534 bp) of the complete histidine ammonium lyase-like
gene generated using primers C15: 5P-CTCATATGTCCC-
GCCCCCGCTTGAACA-3P and C16: 5P-GGCTGCAGCTGTC-
CGCGCGTCGCGGT-3P cloned into the vector resulting in
pCBS20. This plasmid was digested with StuI/XhoI, sticky ends
were blunted with Klenow enzyme and the fragment religated
giving pCBS21. pCBS21 contains the 5P-end of the gene (760
bp) and was used for electroporation three times, but no trans-
formants could be generated.
4.4. Production and analysis of myxalamids and further secondary
metabolites from S. aurantiaca Sga15 and its descendants
For antibiotic production the mutants were cultivated in Zein
liquid medium containing Zein 0.8%, peptone from casein tryp-
tically digested 0.1%, MgSO4W7H2O, 0.1%, kanamycin 60 Wg/ml,
HEPES bu¡er 50 mM, pH 7.2, and 1% of the adsorber resin AD-
16 (Rohm and Haas). Batch cultures of 100 ml in 250 ml Erlen-
meyer £asks were incubated at 30‡C on a gyratory shaker at 160
rpm for 4^5 days.
After cultivation of the mutants, both the cell mass and the
adsorber resin contained secondary metabolites and were ex-
tracted together twice with acetone. The spectrum of secondary
metabolites produced by the di¡erent mutants was determined in
aliquots of concentrated acetone extracts by diode array detected
HPLC analysis using a Hewlett Packard series 1100 instrument.
Chromatographic conditions were as follows: Column ET 125U2
mm and precolumn, Nucleosil120-5-C18 ; solvent used: 0.2%
aqueous acetic acid (A) and acetonitrile (B). For the ¢rst 5 min
a mixture of solvent A and B (1:1) was used. Subsequently (5^15
min), the percentage of solvent B was increased in a gradient up
to 80%; £ow rate 0.5 ml/min; detection 200^400 nm.
The assignment of the di¡erent myxalamid structures was
based on diode array coupled mass spectrometry which was
also used to determine whether the mutants created were indeed
myxalamid non-producers.
Nucleotide accession number: The nucleotide sequence re-
ported here has been submitted to the EMBL database under
accession number AF319998.
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